Interest in and exposure to headache disorders among neurology residents in Denmark: A nationwide cross-sectional survey.

"CONFLICT OF INTEREST Malene Glavind Holmsted Kristensen reports no conflicts of interest. Thien Phu Do reports no conflicts of interest. Patricia Pozo‐Rosich has received honoraria as a consultant and speaker for AbbVie, Amgen, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, and Teva. Her research group has received research grants from AbbVie, Novartis, Teva, AGAUR, FEDER RIS3CAT, la Caixa Foundation, Migraine Research Foundation, Instituto Investigación Carlos III, EraNet Neuron, International Headache Society, MICINN, PERIS; and has received funding for clinical trials from Alder, Biohaven, Electrocore, Eli Lilly, Lundbeck, Novartis, and Teva. She is the Honorary Secretary of the Executive Board of the International Headache Society. She is in the editorial board of Revista de Neurologia. She is an associate editor for Cephalalgia, Frontiers of Neurology, Headache, Neurologia and a scientific advisor of The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She was the Coordinator of the Headache Study Group of the Spanish Neurological Society from 2014–2018. She is the founder of www.midolordecabeza.org. PPR does not own stocks from any pharmaceutical company. Faisal Mohammad Amin has received honoraria and personal fees from Teva, Lundbeck, Novartis, Eli Lilly for lecturing or participating in advisory boards."